Thursday, July 25th, 2024

50,000 Women Screened For Breast Cancer Under The ‘Swasth Mahila, Swasth Goa’ Initiative With iBreastExam

‘Swasth Mahila, Swasth Goa’ Event

A coalition of partners lead the fight against breast cancer

Panaji (Goa) [India], January 31: Breast cancer screening of 50,000 women across Goa has been successfully completed under the ‘Swasth Mahila, Swasth Goa’ initiative, an innovation-led public health initiative of cricketer Yuvraj Singh’s YouWeCan Foundation, the Government of Goa, the SBI Foundation and UE LifeSciences. Launched in October 2021, the project aims to screen 1 lakh women in Goa for breast cancer over two years, ensuring that approximately 50% of the age-eligible female population in the State is screened. The SBI Foundation & the Indian Institute of Banking and Finance have funded the project and UE LifeSciences is the technology partner.

The initiative offers 1,00,000 women free education, awareness, and breast examinations with the help of iBreastExam, an award-winning, US FDA-cleared hand-held medical device. The device allows health workers to identify breast lumps within minutes, instantly at the point of care, without any pain or harmful radiation.

“We now have an excellent technology-led program to win the fight against breast cancer by making early detection reach women right in the community,” said Mr. Vishwajeet Rane, Health Minister of Goa. He added, “iBreastExam has a big impact in Goa. It has enabled us to screen 50,000 women quickly and effectively identify early-stage breast lumps before it is too late. We can track every breast exam and navigate the patients to timely treatment. Most of these women had never received a preventive breast exam before.” 

Regarding the progress of this project, Mr. Yuvraj Singh said, “I am delighted that we have successfully screened over 50,000 women through the Swasth Mahila Swasth Goa Initiative. I thank Mr. Vishwajeet Rane, Honourable Health Minister of Goa, for his unconditional support in making this project a success. I also thank our CSR partners, SBI Foundation, and The Indian Institute of Banking and Finance and our technology partner UE LifeSciences. Most importantly I wholeheartedly thank the true heroes, all the doctors, nurses and healthcare professionals from the Directorate of Health Services, Goa Medical College and the YouWeCan team for making this project a great success.”

Dr. Anupama Borkar said that “The initiative is working really well. So far 1241 suspected breast tissue anomalies were detected out of which 24 asymptomatic women with early-stage breast cancer were diagnosed and treated. The average age of the population screened is 44 years and that of the diagnosed patients is 43 years.”

The Swasth Mahila, Swasth Goa initiative provides women with Breast Cancer S.E.W.A. – Screening, Education, Wellness, and Awareness for breast cancer. It creates a patient-friendly healthcare ecosystem for referrals and follow-up for free breast cancer diagnosis and treatment. Free-of-cost breast cancer screening is being conducted at 35 Health Centres across Goa, along with multiple outreach camps. 24 asymptomatic women with early-stage breast cancer have been diagnosed and treated. All the suspected cases have been referred to the Goa Medical College & Hospital and district hospitals for further investigations and complete treatment. It is to be noted that free treatment is being provided for all positive cases with the support of the Government of Goa.

As per Mr. Sanjay Prakash, Managing Director & CEO, SBI Foundation, “I congratulate all stakeholders on achieving this huge landmark. We must use this momentum to collectively strive harder to reach our target of screening 1 lakh women at the earliest to attain our objective of Swasth Mahila Swasth Goa, thereby making Goa a model state for breast cancer screening. 

“Innovations like iBreastExam ultimately depend on last-mile partners to make that life-saving impact in the community. We are thankful to Mr. Rane, the entire team of the Goa Government and the health workers who are dedicating their time and effort to bring women life-saving access to early detection. We share the success with YouWeCan Foundation and thank SBI Foundation and IIBF for the CSR support”, said Ms. Gauri Godse-Navalkar, UE LifeSciences Country Head – India.

The YouWeCan Foundation is a non-profit organization registered under the Bombay Public Trust Act 1950. Established by international cricketer and cancer survivor Yuvraj Singh in 2012, the Foundation works extensively in the field of cancer control in India, focusing on awareness, screening, patient support, and survivor empowerment. To date, 1,50,000 people have been screened by the Foundation for different types of cancer, 1,25,000 students have been sensitized in anti-tobacco workshops, 30,000 women have been sensitized on self-breast examination, and 24,000 men have been counselled for tobacco cessation. Moreover, 150 cancer survivor students have been supported through the YouWeCan Scholarship, and 15 people have been supported through the YouWeCan Cancer Treatment Fund. www.youwecan.org.

SBI Foundation is the CSR arm of the State Bank of India. True to its tradition of service beyond banking, the foundation currently works in over 27 states and union territories of India on rural development, healthcare, education, livelihood and skill development, youth empowerment, promotion of sports, and more. SBI Foundation believes in reflecting the ethos of the SBI group in running ethical interventions, promoting growth and equality, and creating a positive impact on society. www.sbifoundation.in

UE LifeSciences is an award-winning women’s health company making early detection of leading cancers in women equitable and accessible globally. Its hallmark product, iBreastExam, is an FDA-cleared hand-held device that enables primary health workers to identify breast lumps early, in just a few minutes, without any pain or radiation. Over 2 million breast exams are enabled worldwide. UE LifeSciences is a member of the American Cancer Society and UICC (Union for International Cancer Control). Recently the company has announced a US distribution partnership with Siemens Healthineers and has won Global Women’s HealthTech award from The World Bank, IFC, and CTA. www.uelifesciences.com

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Leave a Reply

Your email address will not be published. Required fields are marked *